Sanofi Statistics
Total Valuation
Sanofi has a market cap or net worth of $113.70 billion. The enterprise value is $128.56 billion.
Important Dates
The next confirmed earnings date is Thursday, April 23, 2026, before market open.
| Earnings Date | Apr 23, 2026 |
| Ex-Dividend Date | May 9, 2025 |
Share Statistics
Sanofi has 2.44 billion shares outstanding. The number of shares has decreased by -2.43% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 2.44B |
| Shares Change (YoY) | -2.43% |
| Shares Change (QoQ) | -0.44% |
| Owned by Insiders (%) | 0.02% |
| Owned by Institutions (%) | 48.81% |
| Float | 1.08B |
Valuation Ratios
The trailing PE ratio is 12.39 and the forward PE ratio is 9.71.
| PE Ratio | 12.39 |
| Forward PE | 9.71 |
| PS Ratio | 2.07 |
| Forward PS | 2.41 |
| PB Ratio | 1.35 |
| P/TBV Ratio | 7.72 |
| P/FCF Ratio | 10.97 |
| P/OCF Ratio | 9.01 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 8.66, with an EV/FCF ratio of 12.40.
| EV / Earnings | 14.01 |
| EV / Sales | 2.34 |
| EV / EBITDA | 8.66 |
| EV / EBIT | 11.35 |
| EV / FCF | 12.40 |
Financial Position
The company has a current ratio of 1.09, with a Debt / Equity ratio of 0.28.
| Current Ratio | 1.09 |
| Quick Ratio | 0.66 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | 1.58 |
| Debt / FCF | 2.30 |
| Interest Coverage | 18.17 |
Financial Efficiency
Return on equity (ROE) is 6.66% and return on invested capital (ROIC) is 9.35%.
| Return on Equity (ROE) | 6.66% |
| Return on Assets (ROA) | 4.65% |
| Return on Invested Capital (ROIC) | 9.35% |
| Return on Capital Employed (ROCE) | 9.80% |
| Weighted Average Cost of Capital (WACC) | 5.54% |
| Revenue Per Employee | $732,842 |
| Profits Per Employee | $122,564 |
| Employee Count | 74,846 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 1.32 |
Taxes
In the past 12 months, Sanofi has paid $1.22 billion in taxes.
| Income Tax | 1.22B |
| Effective Tax Rate | 17.33% |
Stock Price Statistics
The stock price has decreased by -15.92% in the last 52 weeks. The beta is 0.36, so Sanofi's price volatility has been lower than the market average.
| Beta (5Y) | 0.36 |
| 52-Week Price Change | -15.92% |
| 50-Day Moving Average | 46.37 |
| 200-Day Moving Average | 48.23 |
| Relative Strength Index (RSI) | 57.41 |
| Average Volume (20 Days) | 4,134,231 |
Short Selling Information
The latest short interest is 7.33 million, so 0.30% of the outstanding shares have been sold short.
| Short Interest | 7.33M |
| Short Previous Month | 6.56M |
| Short % of Shares Out | 0.30% |
| Short % of Float | 0.68% |
| Short Ratio (days to cover) | 1.64 |
Income Statement
In the last 12 months, Sanofi had revenue of $54.85 billion and earned $9.17 billion in profits. Earnings per share was $7.48.
| Revenue | 54.85B |
| Gross Profit | 39.68B |
| Operating Income | 11.33B |
| Pretax Income | 7.07B |
| Net Income | 9.17B |
| EBITDA | 14.84B |
| EBIT | 11.33B |
| Earnings Per Share (EPS) | $7.48 |
Full Income StatementBalance Sheet
The company has $9.01 billion in cash and $23.87 billion in debt, with a net cash position of -$14.86 billion or -$6.09 per share.
| Cash & Cash Equivalents | 9.01B |
| Total Debt | 23.87B |
| Net Cash | -14.86B |
| Net Cash Per Share | -$6.09 |
| Equity (Book Value) | 84.20B |
| Book Value Per Share | 69.39 |
| Working Capital | 3.06B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $12.62 billion and capital expenditures -$2.07 billion, giving a free cash flow of $10.37 billion.
| Operating Cash Flow | 12.62B |
| Capital Expenditures | -2.07B |
| Depreciation & Amortization | 3.45B |
| Net Borrowing | 1.73B |
| Free Cash Flow | 10.37B |
| FCF Per Share | $4.25 |
Full Cash Flow StatementMargins
Gross margin is 72.34%, with operating and profit margins of 20.66% and 16.72%.
| Gross Margin | 72.34% |
| Operating Margin | 20.66% |
| Pretax Margin | 12.89% |
| Profit Margin | 16.72% |
| EBITDA Margin | 27.05% |
| EBIT Margin | 20.66% |
| FCF Margin | 18.90% |
Dividends & Yields
This stock pays an annual dividend of $1.60, which amounts to a dividend yield of 3.43%.
| Dividend Per Share | $1.60 |
| Dividend Yield | 3.43% |
| Dividend Growth (YoY) | 8.13% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 21.36% |
| Buyback Yield | 2.43% |
| Shareholder Yield | 5.86% |
| Earnings Yield | 8.07% |
| FCF Yield | 9.12% |
Dividend DetailsAnalyst Forecast
The average price target for Sanofi is $58.00, which is 24.41% higher than the current price. The consensus rating is "Buy".
| Price Target | $58.00 |
| Price Target Difference | 24.41% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 4.58% |
| EPS Growth Forecast (5Y) | 13.02% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |
